![](/img/cover-not-exists.png)
Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
Xiaoqin Li, Shan Liu, Hangang Gu, Deqiang WangVolume:
138
Language:
english
DOI:
10.1007/s00432-012-1278-z
Date:
November, 2012
File:
PDF, 372 KB
english, 2012